These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36951032)

  • 21. Forkhead box protein O3a promotes glioma cell resistance to temozolomide by regulating matrix metallopeptidase and β-catenin.
    Sun D; Yang S; Zhang X; Li S; Wang L; Chen J; Qiu C; Xu K
    Oncol Lett; 2021 Apr; 21(4):328. PubMed ID: 33692860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Curcumol reverses temozolomide resistance in glioma cells by regulating the UTX/MGMT axis].
    Sun J; Xing J; Tan R; Qian Y; Tian N
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1697-1705. PubMed ID: 37933645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rab18 interacted with V-set and immunoglobulin domain-containing 4 (VSIG4) to involve in the apoptosis of glioma and the sensitivity to temozolomide.
    Yang K; Wang Z
    Bioengineered; 2021 Dec; 12(1):1391-1402. PubMed ID: 33904378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells.
    Chio CC; Chen KY; Chang CK; Chuang JY; Liu CC; Liu SH; Chen RM
    BMC Cancer; 2018 Apr; 18(1):379. PubMed ID: 29614990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Akt and β-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line.
    Yi GZ; Liu YW; Xiang W; Wang H; Chen ZY; Xie SD; Qi ST
    J Neurol Sci; 2016 Aug; 367():101-6. PubMed ID: 27423571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long Noncoding RNA KCNQ1OT1 Confers Gliomas Resistance to Temozolomide and Enhances Cell Growth by Retrieving PIM1 From miR-761.
    Wang W; Han S; Gao W; Feng Y; Li K; Wu D
    Cell Mol Neurobiol; 2022 Apr; 42(3):695-708. PubMed ID: 32897512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyanidin-3-O-glucoside inhibits the β-catenin/MGMT pathway by upregulating miR-214-5p to reverse chemotherapy resistance in glioma cells.
    Zhou Y; Chen L; Ding D; Li Z; Cheng L; You Q; Zhang S
    Sci Rep; 2022 May; 12(1):7773. PubMed ID: 35545654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomal connexin 43 regulates the resistance of glioma cells to temozolomide.
    Yang ZJ; Zhang LL; Bi QC; Gan LJ; Wei MJ; Hong T; Tan RJ; Lan XM; Liu LH; Han XJ; Jiang LP
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma.
    Ni XR; Guo CC; Yu YJ; Yu ZH; Cai HP; Wu WC; Ma JX; Chen FR; Wang J; Chen ZP
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):773-782. PubMed ID: 33074386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents.
    Chen CC; Taniguchi T; D'Andrea A
    J Mol Med (Berl); 2007 May; 85(5):497-509. PubMed ID: 17221219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of potential glioma drug resistance target proteins based on ultra-performance liquid chromatography-mass spectrometry differential proteomics.
    Li D; Yan J; Li K; Yang Q; Bian L; Lin B; Liu X; Xi Z
    PeerJ; 2023; 11():e16426. PubMed ID: 38054015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-1297 sensitizes glioma cells to temozolomide (TMZ) treatment through targeting adrenomedullin (ADM).
    He Z; Cheng M; Hu J; Liu L; Liu P; Chen L; Cao D; Tang J
    J Transl Med; 2022 Oct; 20(1):443. PubMed ID: 36183123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulation of miR-497 confers resistance to temozolomide in human glioma cells by targeting mTOR/Bcl-2.
    Zhu D; Tu M; Zeng B; Cai L; Zheng W; Su Z; Yu Z
    Cancer Med; 2017 Feb; 6(2):452-462. PubMed ID: 28064447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells.
    Nadkarni A; Shrivastav M; Mladek AC; Schwingler PM; Grogan PT; Chen J; Sarkaria JN
    J Neurooncol; 2012 Dec; 110(3):349-57. PubMed ID: 23054561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circ-VPS18 Knockdown Enhances TMZ Sensitivity and Inhibits Glioma Progression by MiR-370/RUNX1 Axis.
    Li W; Ma Q; Liu Q; Yan P; Wang X; Jia X
    J Mol Neurosci; 2021 Jun; 71(6):1234-1244. PubMed ID: 33188501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma.
    Xu JX; Yang Y; Zhang X; Luan XP
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1922-1931. PubMed ID: 32141561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction.
    Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS
    J Neurooncol; 2014 Aug; 119(1):91-100. PubMed ID: 24842385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma.
    Ding C; Yi X; Chen X; Wu Z; You H; Chen X; Zhang G; Sun Y; Bu X; Wu X; Lin Z; Gu J; Lin Y; Kang D
    J Exp Clin Cancer Res; 2021 May; 40(1):164. PubMed ID: 33975615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways.
    Sun S; Lee D; Ho AS; Pu JK; Zhang XQ; Lee NP; Day PJ; Lui WM; Fung CF; Leung GK
    Neuro Oncol; 2013 May; 15(5):562-77. PubMed ID: 23444257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.